MEDI SOFT
ActiveFrom the official registers: KBO 41 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
MEDI SOFT has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €4.5m and a net result of -€962,053. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 90% of 361 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Board 1
Statutory auditor 1
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- began earlier
- end not dated
| Name | Functions and periods |
|---|---|
| BUDINA Jaroslav |
|
| Callens Vandelanotte SA |
|
| ABBOTT Paul |
|
| BOUTEILLE Isabelle |
|
| HOSAKO Ken |
|
| Xavier Giraud |
|
| Rudi Vullers |
|
| SHIN Yoon Ju |
|
| Yeon Ju Shin |
|
| Paul A. Abott |
|
| Frédéric Gavage |
|
| Matthew Margolies |
|
| Earl LAWSON |
|
| AUSTIN Todd |
|
| MARGOLIES Matthew Scott |
|
| SCHILDKRAUT Lew |
|
The board according to the articles of association
Board and representation
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Administrateur unique, tous les pouvoirs d'administration et de représentation”deed of 07-04-2026 (in French)
- Power of attorneyA power of attorney lets someone perform specific acts on the company's behalf.
- One provision in the deeddeed of 26-08-2025 (in French)
Audit, dissolution and liquidation
- Dissolution ruleThe articles set when and by whom the company can be dissolved.
- “Dissolution”
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Assemblée générale peut limiter à tout moment par majorité simple, tous pouvoirs article 2:87 Code des sociétés et des associations sans…”
deed of 07-04-2026 (in French)
Owners and capital
Shareholders
1 ownerOwners 1
- BTL HOLDINGS LIMITEDCYparentSourceown accounts 31-03-2026100%
Former owners (1)
-
100%
Capital transactions
- MGC Diagnostics Belgium SRL (BE 0555.714.087) 54,124 shares · €1,164,992.05 · “entièrement libérées”
- MGC Diagnostics Belgium (BE 0555.714.087) 39,370 shares · €847,435.39 · “entièrement libérées”
- MGC Diagnostics Belgium (BE 0555.714.087) actionnaire unique · all shares
- MGC Diagnostics Belgium (BE 0555.714.087) 308,643 shares · €6,643,369.93 · “entièrement libérées”
- MGC Diagnostics Belgium €3,000,000
- 07-04-2026 Capital stated in the deed · €10,844,704.40 · 503,831 shares
- 10-11-2025 Capital increase of €1,164,992.05 · to €10,844,704.40 · 54,124 new shares · in kind
- 12-09-2025 Capital increase of €847,435.39 · to €9,679,712.35 · 39,370 new shares · in kind
- 26-08-2025 Capital increase of €6,643,369.93 · to €8,832,276.96 · 308,643 new shares · in kind
- 04-11-2022 Capital increase of €3,000,000 · to €4,293,650 · 71,054 new shares · apports de créances
- 04-11-2022 Capital reduction of €2,104,742.97 · to €2,188,907.03 · to absorb losses
Shares according to the articles of association
Capital, shares and profit
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- One provision in the deed
- Authorised capitalThe board may raise the capital up to this amount without a new shareholder decision.
- “Jour fixé par la loi comme point de départ, autorisation”
deed of 04-11-2022 (in French)